Glaxo gets ready for next pandemic after hiccups in Covid vaccine

Pharma giant is talking with the UK and other governments about building facilities to bring vaccine development onshore before the next crisis.

GlaxoSmithKline Plc fell behind in the Covid-19 vaccine race, but now the drugmaker is working to make sure it’s on the front lines of the next pandemic.

The British pharma giant is talking with the U.K. and other governments about building facilities to bring vaccine development and production onshore before the next crisis, said Roger Connor, its vaccines chief. The labs would offer a range of vaccine technologies to tackle deadly viruses of the future, he said in an interview.

“When every government does their after-action review from this pandemic, they’ll start to think about manufacturing within their own boundary,